Likewise, RRMS patients featured higher percentages of CD19+CD20− DN Bc (Bc 2), CD21− DN memory Bc (Bc 21), and Pc (Bc 23) and a reduction in activated TZB (Bc 5). Here, CD19 is linked to relapsing-remitting multiple sclerosis.